Villis Paulo C M, de Macedo Alessandra T, Furtado Haryne L A, Fontenelle Pedro H C, Gonçalves Ingrid S, Mendes Thayariane L, Motta Brenda L A, Marinho Pedro L L, Pinheiro Aruanã J M C R, Lima-Neto Lídio G, Monteiro Cristina A, da Silva Luís C N, Ferreira Gabriella F, Holanda Rodrigo A, Santos Julliana R A
Laboratório de Eletroquímica e Biotecnologia, Universidade Ceuma, São Luís, Brazil.
Laboratório de Microbiologia Ambiental, Universidade Ceuma, São Luís, Brazil.
Front Microbiol. 2021 Jan 18;11:568258. doi: 10.3389/fmicb.2020.568258. eCollection 2020.
Cryptococcosis, caused by yeasts of the genus , is an infectious disease with a worldwide distribution. and are the species that commonly cause this disease in humans; however, infections caused by , especially in immunocompromised patients, are increasingly being reported. Owing to the increase in the resistance of fungi to antifungals, and a lack of treatment options, it is important to seek new therapeutic alternatives such as natural products. Among these are plant species such as , which is used in folk medicine to treat various diseases. This study aimed to evaluate the activity of the acetate fraction of leaf extract against environmental and clinical isolates of . Three environmental isolates of , PMN, PMA, and PJL II, isolated from soils of different municipalities in the state of Maranhão, a clinical isolate, , from a patient with neurocryptococcosis, and a standard strain of (ATCC 32068) were used. The minimum and fractional inhibitory concentrations (MIC and FIC, respectively) and time-kill curve of the extract and fluconazole were determined to assess the susceptibility profile of the fungal isolates. Larvae of were infected with strains, and the effects of acetate fraction of extract and fluconazole on the survival and fungal burden were determined. The extract activity was tested against pre-formed biofilms. The acetate fraction of extract showed promising antifungal activity against all the species of evaluated in this study, with an MIC value lower than that of fluconazole. The indices obtained in the FIC test indicated that the antimicrobial effect of the combination of the extract and antifungal was indifferent for 80% of the isolates. The acetate fraction reduced the pre-formed biofilm of some isolates, showing better activity than fluconazole, which is consistent with results from fluorescence microscopy. This is the first study on the use of and its ability to inhibit biofilms; therefore, further studies and tests are needed to investigate the components and mechanism of action of against cryptococcosis agents.
隐球菌病由隐球菌属酵母菌引起,是一种在全球范围内传播的传染病。新型隐球菌和格特隐球菌是通常导致人类感染这种疾病的菌种;然而,由罗伦隐球菌引起的感染,尤其是在免疫功能低下患者中,报告日益增多。由于真菌对抗真菌药物的耐药性增加,且缺乏治疗选择,寻求天然产物等新的治疗替代方案很重要。其中包括一些植物物种,如在民间医学中用于治疗各种疾病的巴西人参。本研究旨在评估巴西人参叶提取物乙酸乙酯部位对罗伦隐球菌环境分离株和临床分离株的活性。使用了从马拉尼昂州不同城市土壤中分离的三株罗伦隐球菌环境分离株PMN、PMA和PJL II、一株来自神经隐球菌病患者的临床分离株以及一株罗伦隐球菌标准菌株(ATCC 32068)。测定提取物和氟康唑的最低抑菌浓度和分级抑菌浓度(分别为MIC和FIC)以及时间杀菌曲线,以评估真菌分离株的药敏情况。用罗伦隐球菌菌株感染果蝇幼虫,并测定巴西人参提取物乙酸乙酯部位和氟康唑对其存活和真菌负荷的影响。测试提取物对预先形成的生物膜的活性。巴西人参提取物乙酸乙酯部位对本研究中评估的所有罗伦隐球菌菌种均显示出有前景的抗真菌活性,其MIC值低于氟康唑。FIC试验获得的指数表明,提取物与抗真菌药物联合使用的抗菌效果对80%的分离株无差异。巴西人参乙酸乙酯部位减少了一些分离株预先形成的生物膜,显示出比氟康唑更好的活性,这与荧光显微镜检查结果一致。这是关于巴西人参及其抑制罗伦隐球菌生物膜能力的首次研究;因此,需要进一步的研究和试验来探究巴西人参抗隐球菌病原体的成分和作用机制。